SCHEMBL7556151

SCHEMBL7556151

CS(=O)(=O)c1nccc(-c2cc(C3CCN(C(=O)OCc4ccccc4)CC3)nnc2-c2cccc(C(F)(F)F)c2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 9/20 0.47
MAPK12 P53778 9/20 0.47
MAPK11 Q15759 9/20 0.47
MAPK14 Q16539 9/20 0.47
TRPC3 Q13507 3/20 0.43
TRPC7 Q9HCX4 3/20 0.43
JAK3 P52333 2/20 0.43
EGFR P00533 1/20 0.43
CYP3A4 P08684 1/20 0.43
BRAF P15056 1/20 0.43
MAPK10 P53779 1/20 0.43
KCNH2 Q12809 1/20 0.43
ERBB4 Q15303 1/20 0.43
F2R P25116 1/20 0.42
TRPV4 Q9HBA0 1/20 0.41
CETP P11597 1/20 0.41
FAAH O00519 1/20 0.40
GPR119 Q8TDV5 1/20 0.40
MAPK9 P45984 1/20 0.39
JAK2 O60674 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7670671 0.94 TRPC3 (0.43) MAPK13MAPK12MAPK11MAPK14TRPC3
SCHEMBL7529385 0.88 MAPK13 (0.48) MAPK13MAPK12MAPK11MAPK14TRPC3
SCHEMBL5752224 0.88 TRPC3 (0.43) MAPK13MAPK12MAPK11MAPK14TRPC3
SCHEMBL6170828 0.86 MAPK13 (0.49) MAPK13MAPK12MAPK11MAPK14TRPC3
SCHEMBL6171325 0.86 MAPK13 (0.48) MAPK13MAPK12MAPK11MAPK14TRPC3
SCHEMBL7469105 0.85 TRPC3 (0.44) MAPK13MAPK12MAPK11MAPK14TRPC3
SCHEMBL7463352 0.84 GRIN2B (0.46) MAPK13MAPK12MAPK11MAPK14TRPC3
SCHEMBL7468591 0.82 TRPC3 (0.42) MAPK13MAPK12MAPK11MAPK14TRPC3
SCHEMBL7679585 0.82 GRIN2B (0.46) TRPC3TRPC7CYP3A4F2RTRPV4
SCHEMBL7678065 0.79 MAPK14 (0.62) MAPK13MAPK12MAPK11MAPK14MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1131314-A4 COMPOUNDS HAVING CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2002-05-02 EP disclosed
US-6350744-B1 PYRMIDINE OR PYRIDINE DERIVATIVES; ANTIARTHRITIC AND ANTIINFLAMMATORY AGENTS; CACHEXIA TREATMENT; INTERLEUKIN AND TUMOR NECROSIS FACTOR INHIBITORS MERCK & CO., INC. 2002-02-26 US disclosed
EP-1131314-A1 COMPOUNDS HAVING CYTOKINE INHIBITORY ACTIVITY Merck & Co., Inc. (US) 2001-09-12 EP disclosed
WO-2000031065-A1 COMPOUNDS HAVING CYTOKINE INHIBITORY ACTIVITY MERCK & CO., INC. (US) 2000-06-02 WO disclosed